Senator Investment Group LP Q3 2022 vs. Q4 2022 13F Holdings Comparison
Ava Hoppe | 25 April, 2023
Senator Investment Group LP, a New York-based hedge fund, just released its 13F report for the third quarter of 2022. The report, which discloses the fund's quarterly holdings, reveals that the fund's top three holdings were SPDR S&P 500 ETF TR, Humana Inc, and Danaher Corporation. However, the fund made some significant changes to its portfolio in the fourth quarter of 2022. In this blog post, we will provide an overview of Senator Investment Group LP's Q3 2022 vs. Q4 2022 13F holdings comparison, highlighting the changes made to its top holdings and discussing what these changes could mean for the fund’s future.
SPDR S&P 500 ETF TR
Senator Investment Group LP's largest position in Q3 2022 was SPDR S&P 500 ETF TR, with 110,000 shares valued at $39,290,000. However, the fund significantly increased its position in the ETF in Q4 2022, adding 476,000 shares and bringing the total number of shares held to 586,000, with a total value of $224,103,000. This represents a substantial increase of 470.4% in the market value of the fund's holdings in the ETF, indicating that the fund is bullish on the US stock market's prospects for the near future.
Humana Inc
Humana Inc was Senator Investment Group LP's second-largest position in Q3 2022, with 200,000 shares valued at $97,038,000. However, the fund reduced its position in the company by 50% in Q4 2022, selling 50% of its shares and holding 150,000 shares, with a total value of $76,828,000. This represents a decrease of 20.8% in the market value of the fund's holdings in the company, suggesting that the fund is bearish on the future prospects of the healthcare company.
Danaher Corporation
Danaher Corporation was Senator Investment Group LP's third-largest position in Q3 2022, with 125,000 shares valued at $32,286,000. However, the fund increased its position in the company by 100% in Q4 2022, adding 125,000 shares and bringing the total number of shares held to 250,000, with a total value of $66,355,000. This represents an increase of 105.5% in the market value of the fund's holdings in the company, indicating that the fund is bullish on the company's growth prospects.
Conclusion
Senator Investment Group LP's Q3 2022 vs. Q4 2022 13F holdings comparison reveals some significant changes to its top holdings. While the fund remains bullish on the US stock market, it has reduced its position in Humana Inc, indicating a bearish outlook on the company's prospects. However, the fund has extended its bet on Danaher Corporation, implying its confidence in the company's growth potential. These changes may have implications for the future of the fund, and investors may want to keep an eye on Senator Investment Group LP's holdings in the coming quarters to see if these trends continue.
Other Posts
- Shaking Up the Portfolio: OppenheimerFunds Q4 2018 vs. Q1 2019 Holdings Comparison
- Investment Fund Aristotle Capital Boston Q3 vs Q4 2022: A Comprehensive Overview
- Polen Capital Management LLC Q3 2022 vs Q4 2022: A Look at the Changes in Holdings
- Valeo Financial Advisors, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Sageview Capital LP Sells Off Significant Tech and Fitness Holdings: Analysis of Q2 and Q3 13F Filings
- Compass Group LLC's Q3 vs Q4 2022: A Look at the Top 15 Company Holdings
- A Look into Sicart Associates LLC Q4 2022 vs. Q1 2023 Fund Holdings
- Stone House Investment Management, LLC's Q3 and Q4 2022 13F Holdings Comparison Report Highlights Significant Changes in Holdings and Shifting Portfolio Strategy
- Pacific Global Investment Management Co Q4 2022 vs. Q1 2023 13F Holdings Comparison
- Prescott Group Capital Management's Q3 vs. Q4 2022 Holdings Report: Winners and Losers